WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MORE LIFE wurde als Wortmarke am 10.02.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1541888 |
| Länder | 
|
| Basismarke |
Nr. ,
18. August 2024
|
| Anmeldedatum | 10. Februar 2020 |
| Ablaufdatum | 10. Februar 2030 |
Markeninhaber
1182 Broadway, #14B
New York NY 10001
US
New York NY 10001
US
Markenvertreter
Lowenstein Sandler LLP,
One Lowenstein Drive
US
Waren und Dienstleistungen
09
Downloadable software featuring the use of artificial
intelligence (AI) for interpreting magnetic resonance
imaging (MRI) scans for the purposes of detecting cancer and
other health risks; downloadable software in the nature of a
mobile application for recording, analysis, storage,
manipulation and organization of magnetic resonance imaging
(MRI) results, health screening results, genetic and
molecular data; downloadable software in the nature of a
mobile application for providing access to multiple
databases that contain aggregated results of molecular
biology testing and genotyping; downloadable electronic
publications in the nature of electronic reports, articles,
bulletins, newsletters in the fields of cancer screening,
health screening, genetic testing, genotyping technologies,
genetic screening, phenotyping, molecular analytics, and
ancestry
41
Providing an online resource center, namely, online
non-downloadable articles and papers in the nature of
articles, journals, brochures, leaflets, guides and manuals
in the fields of cancer screening tests, genetic testing and
genotype technologies; providing a website featuring online
non-downloadable publications in the nature of articles,
journals, brochures, leaflets, guides and manuals in the
fields of cancer screening tests, genetic testing and
genotype technologies (terms too vague in the opinion of the
International Bureau – Rule 13 (2) (b) of the Regulations);
providing online non-downloadable educational publications
in the fields of cancer screening tests, genetic testing and
genotype technologies
42
Providing scientific analysis and informational reports
based upon results of laboratory testing in the field of
cancerous diseases for cancer detection and health screening
purposes; providing scientific analysis and informational
reports based upon results of laboratory testing in the
field of genetics research; providing temporary use of
online non-downloadable software featuring the use of
artificial intelligence (AI) for interpreting magnetic
resonance imaging (MRI) scans for the purposes of detecting
cancer and other health risks; providing temporary use of
online non-downloadable software for recording, analysis,
storage, manipulation and organization of magnetic resonance
imaging (MRI) results, health screening results, genetic and
molecular data; providing online computer databases
featuring information based on aggregated results of
genotyping for research purposes (terms too vague in the
opinion of the International Bureau – Rule 13 (2) (b) of the
Regulations); application service provider (ASP) featuring
software for providing access to multiple databases that
contain aggregated results of genotyping; application
service provider (ASP) featuring software for data
management, data storage, data analysis, report generation,
user identification, and membership identification, all in
the fields of genetics, genetic testing, genetic screening,
genotyping, phenotyping, molecular analytics, and ancestry;
scientific research in the fields of genetics, genetic
testing, genetic screening, genotyping, phenotyping,
molecular analytics, and ancestry
44
Health care services for treating prostate cancer and other
cancers; health care services, namely, disease management
programs; health screening services in the field of prostate
cancer, and other cancers; counseling services in the fields
of health, nutrition and lifestyle wellness; providing
health care information by individual and group counseling;
wellness and health-related consulting services; health care
services, namely, wellness programs; medical imaging
services; human healthcare services namely, treatment of
prostate cancer and other cancers; medical services for the
diagnosis of conditions of the human body, namely, prostate
cancer, breast cancer, speech disorders, and infertility;
medical information, namely, providing informational reports
based upon results of laboratory testing for cancer
detection and health screening purposes; medical
information, namely, providing informational reports for
diagnostic and treatment purposes based upon results of
laboratory testing in the field of genetics; providing
online computer databases featuring information based on
aggregated results of genotyping for diagnostic and
treatment purposes (terms too vague in the opinion of the
International Bureau – Rule 13 (2) (b) of the Regulations)
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 10. Februar 2022 | 2022/7 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 29. Juli 2021 | 2021/30 Gaz | JP | Ablehnung |
| 30. März 2021 | 2021/14 Gaz | GB | Ablehnung |
| 10. Dezember 2020 | 2020/51 Gaz | EM | Ablehnung |
| 10. Februar 2020 | 2020/28 Gaz | US | Eintragung |
ID: 141541888